160 related articles for article (PubMed ID: 12784310)
21. Structure of the human type IV collagen COL4A6 gene, which is mutated in Alport syndrome-associated leiomyomatosis.
Zhang X; Zhou J; Reeders ST; Tryggvason K
Genomics; 1996 May; 33(3):473-9. PubMed ID: 8661006
[TBL] [Abstract][Full Text] [Related]
22. [Esophageal leiomyomatosis revealing an Alport syndrome].
Abbes K; Ayadi L; Makni S; Kharrat M; Affes N; Kallel R; Gouiaa N; Ben Hmida M; Hachicha J; Beyrouti MI; Sellami Boudawara T
Rev Med Interne; 2009 Jan; 30(1):88-90. PubMed ID: 18433941
[TBL] [Abstract][Full Text] [Related]
23. Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome.
Renieri A; Galli L; Grillo A; Bruttini M; Neri T; Zanelli P; Rizzoni G; Massella L; Sessa A; Meroni M; Peratoner L; Riegler P; Scolari F; Mileti M; Giani M; Cossu M; Savi M; Ballabio A; De Marchi M
Am J Med Genet; 1995 Nov; 59(3):380-5. PubMed ID: 8599366
[TBL] [Abstract][Full Text] [Related]
24. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.
Antignac C; Zhou J; Sanak M; Cochat P; Roussel B; Deschênes G; Gros F; Knebelmann B; Hors-Cayla MC; Tryggvason K
Kidney Int; 1992 Nov; 42(5):1178-83. PubMed ID: 1453602
[TBL] [Abstract][Full Text] [Related]
25. [Detection of large deletions in X linked Alport syndrome using competitive multiplex fluorescence polymerase chain reaction].
Wang F; Zhang YQ; Ding J; Yu LX
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):760-767. PubMed ID: 29045953
[TBL] [Abstract][Full Text] [Related]
26. Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in
Zhou X; Wang J; Mao J; Ye Q
Front Med (Lausanne); 2021; 8():766224. PubMed ID: 34778325
[TBL] [Abstract][Full Text] [Related]
27. Alport syndrome and diffuse leiomyomatosis with major morbid events presenting at adult age.
Van Loo A; Vanholder R; Buytaert I; De Paepe A; Praet M; Elewaut A; Lameire N
Nephrol Dial Transplant; 1997 Apr; 12(4):776-80. PubMed ID: 9141011
[No Abstract] [Full Text] [Related]
28. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
Kashtan CE
Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
[TBL] [Abstract][Full Text] [Related]
29. Alport-leiomyomatosis syndrome: an update.
García-Torres R; Orozco L
Am J Kidney Dis; 1993 Nov; 22(5):641-8. PubMed ID: 8238008
[TBL] [Abstract][Full Text] [Related]
30. Alport syndrome with diffuse leiomyomatosis. When and when not?
Miner JH
Am J Pathol; 1999 Jun; 154(6):1633-5. PubMed ID: 10362786
[No Abstract] [Full Text] [Related]
31. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
32. Organization and expression of basement membrane collagen IV genes and their roles in human disorders.
Sado Y; Kagawa M; Naito I; Ueki Y; Seki T; Momota R; Oohashi T; Ninomiya Y
J Biochem; 1998 May; 123(5):767-76. PubMed ID: 9562604
[TBL] [Abstract][Full Text] [Related]
33. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
34. Alport syndrome. A review of the ocular manifestations.
Colville DJ; Savige J
Ophthalmic Genet; 1997 Dec; 18(4):161-73. PubMed ID: 9457747
[TBL] [Abstract][Full Text] [Related]
35. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis.
Antignac C; Heidet L
Contrib Nephrol; 1996; 117():172-82. PubMed ID: 8801045
[No Abstract] [Full Text] [Related]
36. [Diffuse esophageal leiomyomatosis and Alport's syndrome: A case report and review of the literature].
Delteil C; Macagno N; Daniel L; D'Journo XB; Guisiano S; Garcia S; Secq V
Ann Pathol; 2019 Feb; 39(1):36-39. PubMed ID: 30322718
[TBL] [Abstract][Full Text] [Related]
37.
Zhang P; Zhuo L; Zou Y; Li G; Peng K
Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
[No Abstract] [Full Text] [Related]
38. LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis.
Segal Y; Peissel B; Renieri A; de Marchi M; Ballabio A; Pei Y; Zhou J
Am J Hum Genet; 1999 Jan; 64(1):62-9. PubMed ID: 9915944
[TBL] [Abstract][Full Text] [Related]
39. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.
Zhou J; Mochizuki T; Smeets H; Antignac C; Laurila P; de Paepe A; Tryggvason K; Reeders ST
Science; 1993 Aug; 261(5125):1167-9. PubMed ID: 8356449
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular diagnosis of Alport syndrome.
Kashtan CE
Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
